Literature DB >> 11897994

Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells.

Kristen L Hoek1, Gail H Cassell, Lynn B Duffy, T Prescott Atkinson.   

Abstract

BACKGROUND: Mycoplasma pneumoniae is a respiratory tract pathogen that has been associated with severe exacerbations in patients with chronic asthma. Murine models of infection have recently been established, with disease manifestations similar to those observed in human subjects. Previous studies have suggested that this organism is capable of producing activation of a wide range of immunologic cell types.
OBJECTIVE: We sought to determine whether M pneumoniae can induce mast cell activation in the rodent mast cell line RBL-2H3.
RESULTS: After 4 hours of coculture, morphologic changes indicative of activation were observed by means of electron microscopy, and M pneumoniae was identified, by means of immunoelectron microscopy, adhering to mast cell membranes. Coculture of rat basophilic leukemia cells with viable M pneumoniae for 4 hours resulted in net release of beta-hexosaminidase and serotonin into the supernatant. Live, but not heat-killed, organisms induced the release of IL-4 protein into the culture supernatant, with a peak at 4 hours. During coculture with M pneumoniae, production of mRNA for IL-4, IL-6, and TNF-alpha was upregulated after 2 hours and had returned to near baseline by 24 hours after infection.
CONCLUSIONS: We conclude that viable M pneumoniae induces activation of mast cells with release of granule contents, as well as cytokine production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897994     DOI: 10.1067/mai.2002.121951

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

1.  Mast cells protect against airway Mycoplasma pneumoniae under allergic conditions.

Authors:  N M Michels; H W Chu; S C LaFasto; S R Case; M N Minor; R J Martin
Journal:  Clin Exp Allergy       Date:  2010-03-23       Impact factor: 5.018

2.  Mast cells protect mice from Mycoplasma pneumonia.

Authors:  Xiang Xu; Dongji Zhang; Natalya Lyubynska; Paul J Wolters; Nigel P Killeen; Peter Baluk; Donald M McDonald; Samuel Hawgood; George H Caughey
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

Review 3.  The impact of bacterial infection on mast cell degranulation.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

Review 4.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  The effect of vitamin A on secretion of IFN-gamma and IL-4 in A549 cells induced by Mycoplasma pneumoniae.

Authors:  Xiaolan Wu; Xianzhou Liu; Jilu Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

6.  Escherichia coli exposure inhibits exocytic SNARE-mediated membrane fusion in mast cells.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Traffic       Date:  2014-03-07       Impact factor: 6.215

7.  Inhibition of message for FcepsilonRI alpha chain blocks mast cell IL-4 production induced by co-culture with Mycoplasma pneumoniae.

Authors:  Danlin Luo; Yuling Dai; Lynn B Duffy; T Prescott Atkinson
Journal:  Microb Pathog       Date:  2007-10-24       Impact factor: 3.738

8.  Comparative genome analysis of Mycoplasma pneumoniae.

Authors:  Li Xiao; Travis Ptacek; John D Osborne; Donna M Crabb; Warren L Simmons; Elliot J Lefkowitz; Ken B Waites; T Prescott Atkinson; Kevin Dybvig
Journal:  BMC Genomics       Date:  2015-08-16       Impact factor: 3.969

9.  Serum Cytokines and FeNO in School-Aged Children with Mycoplasma pneumoniae Pneumonia.

Authors:  Hai-Li Jin; Lu Zhan; Shu-Fen Mei; Zheng-Yang Shao
Journal:  Med Sci Monit       Date:  2020-06-21

10.  Th1/Th2 Cytokine Profile and Its Diagnostic Value in Mycoplasma pneumoniae Pneumonia.

Authors:  Wei Li; Yu-Jie Liu; Xiao-le Zhao; Shi-Qiang Shang; Lang Wu; Qing Ye; Hui Xu
Journal:  Iran J Pediatr       Date:  2016-01-30       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.